Timothy J. Kieffer

Cell Rep Med. 2022 Apr 19;3(4):100592. doi: 10.1016/j.xcrm.2022.100592.

Abstract

Timothy Kieffer's laboratory has contributed to our knowledge of islet biology and the development of cell-based strategies for insulin replacement for diabetes mellitus. In this Q&A, he discusses his journey in academia and industry and his perspectives on the future challenges and opportunities of this field.

MeSH terms

  • Humans
  • Industry*
  • Insulin* / therapeutic use
  • Male

Substances

  • Insulin